CA Hurwitz
- Hematology top 5%
- Acute Myeloid Leukemia Research 4
-
- Acute Lymphoblastic Leukemia research 6
- Genetics top 10%
- Virus-based gene therapy research 1
- Chronic Lymphocytic Leukemia Research 1
-
- Childhood Cancer Survivors' Quality of Life 1
-
- Lymphoma Diagnosis and Treatment 2
-
- Neutropenia and Cancer Infections 1
-
- Immunotherapy and Immune Responses 1
- Journals
- Blood (5 papers)Leukemia (1 paper)PubMed (2 papers)
- Partner nations
- United StatesPuerto RicoCanada
In The Last Decade
CA Hurwitz
8 papers receiving 478 citations
Peers
Comparison fields: 5 of 42
- Hematology 347
- Public Health, Environmental and Occupational Health 274
- Genetics 95
- Pediatrics, Perinatology and Child Health 92
- Pathology and Forensic Medicine 64
Countries citing papers authored by CA Hurwitz
This map shows the geographic impact of CA Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Hurwitz more than expected).
Fields of papers citing papers by CA Hurwitz
This network shows the impact of papers produced by CA Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Hurwitz. The network helps show where CA Hurwitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside CA Hurwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 121 | |
| 2 | XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors. | 1994 | 11 |
| 3 | 1994 | 2 | |
| 4 | Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors. | 1993 | 10 |
| 5 | 1992 | 34 | |
| 6 | 1992 | 152 | |
| 7 | 1988 | 14 | |
| 8 | 1988 | 141 |
About CA Hurwitz
CA Hurwitz is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 8 papers that have together received 485 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Virus-based gene therapy research (1 paper), Neutropenia and Cancer Infections (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Hematology (347 citations), Public Health, Environmental and Occupational Health (274 citations) and Genetics (95 citations). CA Hurwitz has collaborated with scholars based in United States, Puerto Rico and Canada. Frequent co-authors include Robert A. Krance, David Head, SC Raimondi, Joseph Mirro, DK Kalwinsky, FG Behm, DJ Pullen, MJ Borowitz, RD Barr and Yves Samson. Their work appears in journals such as Blood, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.